Quest Diagnostics: Plasma Phosphorylated-Tau 217

Quest Diagnostics this week introduced its plasma phosphorylated-tau 217 assay, an addition to its AD-Detect portfolio of blood tests for assessing the risk of Alzheimer's disease. The portfolio also includes blood tests for phosphorylated-tau 181, amyloid beta proteins, and APOE isoforms.